Perrigo is a global healthcare company. Co. is a producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays. Co.'s segments are: Consumer Healthcare Americas, which provides products for analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritionals, smoking cessation, animal health, vitamins, minerals and dietary supplements, and other miscellaneous healthcare products; Consumer Healthcare International, which provides products for cough, cold, allergy, sinus, personal care and derma-therapeutics, and anti-parasite; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs. We show 22 historical shares outstanding datapoints in our coverage of PRGO's shares outstanding history.
Understanding the changing numbers of PRGO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like PRGO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching PRGO by allowing them to research PRGO shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
